Responder Analyses for Patient-Reported Outcomes in a Pooled Analysis of Two Phase III Randomized Placebo Controlled Trials of Gefapixant, a P2X3 Receptor Antagonist for the Treatment of Chronic Cough

S.S. Birring, A.H. Morice, J. Smith, L. McGarvey, I.D. Pavord, A. Martin Nguyen, J. Schelfhout, P. Dicpinigaitis, B. Iskold, A. Tzontcheva, Q. Li, D. Muccino, C. La Rosa

Research output: Contribution to journalMeeting abstractpeer-review

Cite this